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Abstract
Several single nucleotide polymorphisms (SNPs) in the Mu Opioid Receptor gene (OPRM1) have been identified
and associated with a wide variety of clinical phenotypes related both to pain sensitivity and analgesic requirements.
The A118G and other potentially functional OPRM1 SNPs show significant differences in their allele distributions
among populations. However, they have not been properly addressed in a population genetic analysis. Population
stratification could lead to erroneous conclusions when they are not taken into account in association studies. The
aim of our study was to analyze OPRM1 SNP variability by comparing population samples of the International Hap
Map database and to analyze a new population sample from the city of Corrientes, Argentina. The results confirm
that OPRM1 SNP variability differs among human populations and displays a clear ancestry genetic structure, with
three population clusters: Africa, Asia, and Europe-America.
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The human OPRM1 gene encodes the mu opioid re-
ceptor (MOR), a G-protein coupled receptor associated
with a wide number of complex neurobiological traits re-
lated to pain. Several single nucleotide polymorphisms
(SNPs) in OPRM1 have been extensively associated with
pain sensitivity, tolerance, and analgesic response (Fernan-
dez Robles et al., 2012). Therefore, the study of OPRM1
genetic variations is clinically relevant.
OPRM1 SNPs can modify receptor properties. The
most studied SNP, A118G (rs1799971), is a frequent non-
conservative substitution in exon I, which gives rise to an
amino acid exchange from asparagine to aspartate at posi-
tion 40 of the protein (N40D) (Bergen et al., 1997). Signifi-
cant differences in the agonist affinity and potency in MOR
activity have been reported for N40D (Bond et al., 1998;
Lopez Soto and Raingo 2012). Additionally, several stud-
ies have correlated N40D with higher pain score and anal-
gesic requirements in clinical studies (Campa et al., 2008;
Sia et al., 2008). In contrast, other studies failed to detect
these clinical associations or presented opposite results
(Lopez Soto et al., 2013). Therefore, further research is re-
quired to elucidate the physiological impact of A118G.
Other SNPs, like C17T (rs1799972), T1443A
(rs540825) and C440G (rs17174794), could also change
the amino acid sequence of MOR (A6V, H402Q, and
S147C, respectively). Additionally, some SNPs located in
intronic regions, like IVS2+691C/G (rs2075572), or pro-
ducing synonymous changes in exonic regions, like
C1570T (rs562859), may not modify the MOR amino
acidic sequence, but have been associated with pain sensi-
tivity and postulated to be a risk factor for schizophrenia
and heroin abuse (Shabalina et al., 2009; Ding et al., 2013;
Sillivan et al., 2013). Thus, coding and non-coding
OPRM1 SNPs could modify MOR properties and physiol-
ogy.
Numerous association studies have reported signifi-
cant differences in OPRM1 SNP allele distributions among
populations (Bergen et al., 1997; Bond et al., 1998;
Gelernter et al., 1999; Tan et al., 2009) but this has not been
addressed in a genetic population analysis. It is well estab-
lished that A118G can reach a specific range of allele fre-
quency depending on the population ancestry under study:
Europeans 10-30%; Asians 36-50%; Hispanics 15-18%
and Africans 1-17% (Bergen et al., 1997; Bond et al., 1998;
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Gelernter et al., 1999; Tan et al., 2009). Our previous re-
sults confirm that A118G SNP genetic variance analysis is
able to detect a population genetic structure (Lopez Soto et
al., 2013). In contrast, rs540825 and rs562859 polymor-
phisms are located in an alternative exon, defining the
MOR-1X isoform of the OPRM1 gene in the intracellular
domain of the receptor (Smith et al., 2005). They are sepa-
rated by 128 base pairs and linkage disequilibrium between
these two SNPs is moderate (r2 = 0.51) (Garriock et al.,
2010). Interestingly, only the rs540825 genetic frequencies
differ by a large margin between Afro-Americans and Eu-
ropean-Americans (Smith et al., 2005). Both population
structure and recent admixture events could be a problem in
association studies, leading to false positive or false nega-
tive associations and consequently erroneous conclusions
(Ziv and Burchard 2003; Freedman et al., 2004). Hence, the
aim of the study was to analyze OPRM1 SNP variability
and to investigate the genetic structure of population sam-
ples from the International HapMap database and a mixed
population sample from Argentina in relation to gene fre-
quency distribution of several pain-related OPRM1 SNPs.
OPRM1 variability has been widely analyzed in
worldwide populations (Levran et al., 2011), but the fre-
quencies of such polymorphisms in Argentinian people
have not been established yet. Considering that there is an
important European and Native American genetic contribu-
tion (Diaz-Lacava et al., 2011; Avena et al., 2012), these
components might impact on the frequencies of OPRM1
SNPs.
The current analysis included a population sample of
108 non-related donors from the city of Corrientes, (prov-
ince of Corrientes, Argentina, CTES), collected under med-
ical supervision in public hospitals. Each individual was
requested to voluntarily participate in this study, and was
asked to sign an Informed Consent. This study was ap-
proved by the Ethics Committee for Biomedical Research
from the Multidisciplinary Institute of Cell Biology
(IMBICE), La Plata, Argentina.
Six SNPs (rs1799971, rs1799972, rs17174794,
rs2075572, rs540825 and rs562859), selected for their abil-
ity to change protein function and/or for their population
frequencies, were genotyped as previously described (Ber-
gen et al., 1997; Gelernter et al., 1999; Smith et al., 2005).
Rs1799971 genotype information from CTES population
previously published by our group (Lopez Soto et al., 2013)
was included in this analysis and extended to 108 samples.
For each marker, the amplified PCR fragments of 6-10 ran-
dom samples were sequenced as a quality control to con-
firm the accuracy of the PCR-RFLP results.
For statistical analysis, allele and genotype frequen-
cies of CTES sample were calculated by direct counting.
Hardy-Weinberg equilibrium was tested (Exact test,
p < 0.05), genetic distances (Fst) among populations were
estimated (Exact test, p < 0.05), and different genetic struc-
tures among populations were tested by Analysis of Molec-
ular Variance (AMOVA, permutation, p < 0.05) using
Arlequin v3.5 (Excoffier et al., 2005). In order to detect
population structure, nine HapMap populations were in-
cluded (www.hapmap.org): Utah residents with Northern
and Western European ancestry from the CEPH collection
(CEU); Han Chinese in Beijing, China (CHB); Chinese in
Metropolitan Denver, Colorado (CHD); Gujarati Indians in
Houston, Texas (GIH); Japanese in Tokyo, Japan (JPT);
Mexican ancestry in Los Angeles, California (MEX);
Maasai in Kinyawa, Kenya (MKK); Tuscan in Italy (TSI)
and African ancestry in Southwest USA (ASW). Popula-
tion samples from Luhya in Webuye, Kenya, and Yoruba in
Ibadan, Nigeria, were not included because the selected
SNPs were genotyped in less than 50% of the total samples
available.
All SNPs analyzed in the CTES sample were bi-
allelic and their frequency distribution presented non-signi-
ficant deviation from Hardy-Weinberg equilibrium (Exact
test, p > 0.05). Additionally, it was found that the most fre-
quent variant was the ancestral allele for all the analyzed
SNPs, ranging from 0.99 (rs1799972) to 0.53 (rs2075572).
On the other hand, while four of the six SNPs (rs1799971,
rs2075572, rs540825, rs562859) showed minor allele fre-
quencies exceeding 1%, thus being able to be considered
polymorphisms, the other two SNPs (rs1799972 and
rs17174794) reached less than 1% allele frequency so they
could be considered as recurrent mutations in CTES sam-
ple.
Corrientes is the capital city of the Province of Cor-
rientes, located on the northeast of Argentina. Its popula-
tion has two main genetic contributions, from Native
American and European people. According to autosomal
and uniparental markers, the genetic background of the
Corrientes population has the same global genetic structure
as that of Argentina as a whole (Diaz-Lacava et al., 2011;
Avena et al., 2012). In Corrientes, European genetic heri-
tage is mainly autosomal, whereas the mitochondrial gene
pool is mostly of Native American ancestry (African heri-
tage is small in all genetic systems). Population substruc-
ture based on autosomal information is very small in Ar-
gentina (Corach et al., 2010). Therefore, Corrientes might
be an adequate population sample to reduce sampling ef-
forts in Argentina in order to perform population genetic
studies at the continental level. Thus the CTES sample was
included in the analysis of population genetic structure.
The International HapMap Project is the major inter-
national research resource to construct a human SNP data-
base that offers information about patterns of variation in
specific populations (International HapMap Consortium
2003). Taking advantage of the availability of the HapMap
Project SNP database, the six SNPs genotype frequencies
of nine populations: CEU, CHB, CHD, GIH, JPT, MEX,
MKK, TSI and ASW were included in the OPRM1 genetic
variability analysis. Thus, in order to identify geographic
structure among these worldwide populations including
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CTES, pairwise variance of population gene frequencies
was calculated (Fst) (Excoffier et al., 2005) (Table 1). Sta-
tistical differences were found (p < 0.01) among popula-
tions tracing ancestry clusters, except between American
(CTES and MEX) and European (CEU and TSI) popula-
tions, which were indistinguishable by the Fst index. This
approach allowed to recognize three clusters: one com-
posed of American and European populations (CTES,
CEU, TSI and MEX), one composed of Asian populations
(CHB, CHD, JPT and GIH) and another one composed of
African populations (ASW and MKK).
Aditionally, two different grouping criteria were con-
sidered in order to test genetic structures based on OPRM1
SNPs variability by AMOVA (Table 2): “all populations”
criteria, which groups all populations together in one
group; and “three groups” criteria, which includes the three
ancestry clusters: the European and American group
(EuAm), the Asian group (As), and the African group (Af).
The results showed that when one group was defined (“all
populations”), variation among populations represented
8.9% of the total variation (Table 2), thus indicating that the
genetic variation is ancestrally structured. Additionally,
when considering the ancestry (EuAm, As and Af) it was
found that the variance component among groups reached a
significant 12.81%, with no differences among populations
within groups. Thus, a genetic structure based on ancestry,
consisting of three groups: the European-American, the
Asian, and the African group was confirmed.
On the other hand, whereas Fst analysis found no dif-
ferentiation between American and European populations,
the possibility of identifying any genetic structure among
these populations was also tested. AMOVA was used by
two criteria: “European ancestry populations” which in-
cludes CTES, CEU, TSI and MEX in a single group, and
“two groups” which corresponds to American (Am) and
European (Eu) populations in separated groups. AMOVA
showed no significant variation among populations, or be-
tween the two groups in either case. Hence, identifying a
genetic structure in American and European populations
using OPRM1 SNP variability by Fst and AMOVA was not
possible.
By means of two population genetic approaches, Fst
and AMOVA, it was found that all the analyzed population
samples were grouped into three clusters corresponding to
different human ancestral lineages: African, Asian, and Eu-
ropean-American. Several studies have demonstrated that
since the time of colonization, the genetic flow between
America and Europe has been very important and has had a
dramatic impact on the current genetic background of
North, Central, and South American populations (Diaz-
154 Structure detected by OPRM1 SNPs.
Table 2 - Analysis of Molecular Variance (AMOVA) among worldwide populations. Values indicate variance component in hierarchical levels in four
genetic structures tested. Asterisks mark statistically significant values (significance test: 1023 permutations, p < 0.05).
Pairwise differences % variation
Within populations Among populations (within groups) Among groups
All populations 91.11* 8.89* -
3 groups (EuAm / As / Af) 87.78* -0.58 12.81*
European ancestry populations 101.29 -1.29 -
2 groups (Eu / Am) 102.47 -0.94 -0.53
EuAm = European and American populations, As = Asian populations, Af = African populations, Eu = European populations Am = American popula-
tions.
Table 1 - Genetic distances between populations. Values indicate population pairwise Fst. Shadings indicate the continental origin of populations as fol-
lows: light gray block = European and American, gray block = Asian, dark gray block = African populations. Asterisks mark statistically significant val-
ues (significance test: 1023 permutations, p < 0.01).
CTES CEU TSI MEX CHB CHD JPT GIH ASW MKK
CTES 0.00000
CEU - 0.03060 0.00000
TSI -0.00256 -0.00984 0.00000
MEX -0.00880 -0.02114 -0.00003 0.00000
CHB 0.07178* 0.14913* 0.06052* 0.07697* 0.00000
CHD 0.11305* 0.17014* 0.10448* 0.11007* -0.00212 0.00000
JPT 0.14357* 0.20374* 0.13548* 0.14233* 0.00785 -0.00043 0.00000
GIH 0.07846* 0.10898* 0.07556* 0.07294* -0.01576 -0.00338 0.00110 0.00000
ASW 0.04789* 0.05385* 0.03497* 0.04293* 0.17912* 0.21191* 0.26375* 0.17033* 0.00000
MKK 0.03454* 0.02272* 0.02544* 0.03417* 0.16738* 0.21235* 0.25623* 0.17665* -0.00014 0.00000
Lacava et al., 2011; Avena et al., 2012). Thus, the historical
demographic events could explain the similarity of Ameri-
can and European populations in OPRM1 SNP variability.
The main limitation of our study is the small number of
SNPs included to perform the genetic population analysis
leading to a possible loss of sensitivity in detecting a popu-
lation structure and an over- or underestimation of group
differentiation. Despite this, our results should be consid-
ered in OPRM1 association studies, for it has been sug-
gested that population stratification between controls and
cases due to genetic background might cause false associa-
tions between a SNP and a specific phenotype.
In conclusion, the study consistently found that
OPRM1 SNP variability clearly displays a population
structure by ancestry. Additionally, this study expanded
our previous results (Lopez Soto et al., 2013) and it is a con-
tribution to coding regions polymorphism knowledge in
Argentinian population. In the future, this information
might be of potential application in palliative therapies,
since OPRM1 polymorphisms affect a wide range of re-
sponses in pain perception pathway.
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